KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 80 filers reported holding KEROS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,505,337 | +305.8% | 204,057 | +411.5% | 0.00% | +200.0% |
| Q2 2023 | $1,603,021 | +153888.6% | 39,896 | +63.7% | 0.00% | 0.0% |
| Q1 2023 | $1,041 | -88.0% | 24,373 | -86.6% | 0.00% | -80.0% |
| Q4 2022 | $8,705 | -99.8% | 181,277 | +176.0% | 0.01% | +150.0% |
| Q1 2022 | $3,572,000 | +15.7% | 65,688 | +24.5% | 0.00% | 0.0% |
| Q4 2021 | $3,086,000 | -57.1% | 52,744 | -71.0% | 0.00% | -50.0% |
| Q3 2021 | $7,195,000 | +44.9% | 181,876 | +55.6% | 0.00% | +33.3% |
| Q2 2021 | $4,965,000 | -38.1% | 116,915 | -10.2% | 0.00% | -50.0% |
| Q1 2021 | $8,018,000 | +29.2% | 130,265 | +48.1% | 0.01% | +50.0% |
| Q4 2020 | $6,204,000 | +1740.9% | 87,956 | +906.5% | 0.00% | – |
| Q3 2020 | $337,000 | – | 8,739 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,412,705 | $99,652,000 | 10.82% |
| CHI Advisors LLC | 433,852 | $30,604,000 | 8.62% |
| VR Adviser, LLC | 672,306 | $47,424,000 | 6.97% |
| Consonance Capital Management LP | 557,095 | $39,297,000 | 3.67% |
| Logos Global Management LP | 450,000 | $31,743,000 | 2.72% |
| RA Capital Management | 1,875,000 | $132,263,000 | 1.85% |
| Nantahala Capital Management | 534,514 | $37,705,000 | 1.17% |
| Orbimed Advisors | 1,679,417 | $118,466,000 | 1.04% |
| Eventide Asset Management | 346,000 | $24,407,000 | 0.37% |
| Atom Investors LP | 49,981 | $3,526,000 | 0.36% |